↓ Skip to main content

Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study

Overview of attention for article published in Breast Cancer Research, July 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

news
1 news outlet
twitter
9 X users
facebook
3 Facebook pages
googleplus
2 Google+ users

Citations

dimensions_citation
103 Dimensions

Readers on

mendeley
72 Mendeley
citeulike
2 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study
Published in
Breast Cancer Research, July 2011
DOI 10.1186/bcr2920
Pubmed ID
Authors

Alina Vrieling, Rebecca Hein, Sascha Abbas, Andreas Schneeweiss, Dieter Flesch-Janys, Jenny Chang-Claude

Abstract

Vitamin D has been postulated to be involved in cancer prognosis. Thus far, only two studies reported on its association with recurrence and survival after breast cancer diagnosis yielding inconsistent results. Therefore, the aim of our study was to assess the effect of post-diagnostic serum 25-hydroxyvitamin D [25(OH)D] concentrations on overall survival and distant disease-free survival.

X Demographics

X Demographics

The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 72 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 72 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 14 19%
Student > Ph. D. Student 11 15%
Other 9 13%
Student > Master 7 10%
Student > Doctoral Student 5 7%
Other 15 21%
Unknown 11 15%
Readers by discipline Count As %
Medicine and Dentistry 31 43%
Biochemistry, Genetics and Molecular Biology 11 15%
Agricultural and Biological Sciences 10 14%
Nursing and Health Professions 2 3%
Engineering 2 3%
Other 5 7%
Unknown 11 15%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 April 2017.
All research outputs
#1,871,773
of 25,373,627 outputs
Outputs from Breast Cancer Research
#158
of 2,052 outputs
Outputs of similar age
#8,463
of 130,746 outputs
Outputs of similar age from Breast Cancer Research
#2
of 14 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,052 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.2. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 130,746 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.